CellaVision AB (publ) (STO:CEVI)
Sweden · Delayed Price · Currency is SEK 180.00
-1.40 (-0.77%)
Oct 31, 2025, 12:59 PM CET
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 4.29 billion as of October 31, 2025. Its market cap has decreased by -38.04% in one year.
Market Cap
4.29B
Enterprise Value
4.17B
Revenue
751.47M
Ranking
n/a
PE Ratio
28.40
Stock Price
180.00
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 372.09M to 4.29B, an increase of 1,053.82%. That is a compound annual growth rate of 14.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 4.29B | -17.24% |
| Dec 30, 2024 | 5.19B | 2.59% |
| Dec 29, 2023 | 5.06B | -7.42% |
| Dec 30, 2022 | 5.46B | -29.58% |
| Dec 30, 2021 | 7.76B | 5.93% |
| Dec 30, 2020 | 7.32B | -3.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 112.77B |
| Getinge AB | 60.82B |
| Sectra AB | 58.15B |
| Medicover AB | 39.10B |
| Camurus AB | 37.23B |
| Asker Healthcare Group AB | 33.00B |
| BioArctic AB | 25.95B |
| AddLife AB | 25.03B |